Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Sell
14
EVH Quote, Financials, Valuation and Earnings
Last price:
$4.02
Seasonality move
:
4.97%
Day range:
$3.81 - $4.02
52-week range:
$3.50 - $12.98
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.22x
P/B ratio:
0.53x
Volume:
4.6M
Avg. volume:
4.7M
1-year change:
-65.16%
Market cap:
$447.5M
Revenue:
$2.6B
EPS (TTM):
-$1.57
Analysts' Opinion
-
Consensus RatingEvolent Health, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 11 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $10.18, Evolent Health, Inc. has an estimated upside of 153.83% from its current price of $4.01.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $6.00 representing -49.63% downside risk from its current price of $4.01.
Fair Value
-
According to the consensus of 11 analysts, Evolent Health, Inc. has 153.83% upside to fair value with a price target of $10.18 per share.
EVH vs. S&P 500
-
Over the past 5 trading days, Evolent Health, Inc. has underperformed the S&P 500 by -4.64% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Evolent Health, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Evolent Health, Inc. revenues have been falling on a year-over-year basis for 3 quarters in a row. In the most recent quarter Evolent Health, Inc. reported revenues of $479.5M.
Earnings Growth
-
Evolent Health, Inc. has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Evolent Health, Inc. reported earnings per share of -$0.24.
Enterprise value:
1.4B
EV / Invested capital:
0.72x
Price / LTM sales:
0.22x
EV / EBIT:
301.87x
EV / Revenue:
0.68x
PEG ratio (5yr expected):
-0.04x
EV / Free cash flow:
-20.24x
Price / Operating cash flow:
11.17x
Enterprise value / EBITDA:
12.45x
Gross Profit (TTM):
$277.4M
Return On Assets:
-5.08%
Net Income Margin (TTM):
-6.24%
Return On Equity:
-13.6%
Return On Invested Capital:
-6.63%
Operating Margin:
0.14%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $1.8B | $2.5B | $2.1B | $621.4M | $479.5M | |
| Gross Profit | $326.3M | $274.3M | $277.4M | $51M | $75.9M | |
| Operating Income | $19.6M | $10.9M | $4.6M | -$12.3M | $658K | |
| EBITDA | $149.4M | $130.7M | $111.6M | $17.4M | $27.5M | |
| Diluted EPS | -$1.03 | -$0.91 | -$1.57 | -$0.27 | -$0.24 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $478.2M | $393.8M | $638.8M | $544M | $570.1M | |
| Total Assets | $1.3B | $1.8B | $2.7B | $2.5B | $2.5B | |
| Current Liabilities | $367.2M | $382M | $615.3M | $523.7M | $429.9M | |
| Total Liabilities | $646M | $903M | $1.6B | $1.5B | $1.6B | |
| Total Equity | $607.5M | $856.1M | $1.1B | $1B | $842.2M | |
| Total Debt | $301.8M | $470.3M | $815.2M | $816.2M | $1.1B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $88.9M | $134.4M | -$36.2M | $18.7M | $15.8M | |
| Cash From Investing | -$413.9M | -$49.1M | -$102.3M | -$19.7M | -$8.8M | |
| Cash From Financing | $354.8M | -$181.9M | $154.1M | -$9M | -$41.8M | |
| Free Cash Flow | $55.5M | $109.6M | -$68.7M | $12.4M | $6.9M | |
EVH
Sector
Market Cap
$447.5M
$28.4M
Price % of 52-Week High
30.9%
50.35%
Dividend Yield
0%
0%
Shareholder Yield
-1.32%
-1.32%
1-Year Price Total Return
-65.16%
-22.19%
Beta (5-Year)
0.276
0.521
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
14.67%
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$4.10
200-day SMA
Sell
Level
$8.70
Bollinger Bands (100)
Sell
Level
5.85 - 9.93
Chaikin Money Flow
Sell
Level
-71.9M
20-day SMA
Sell
Level
$4.29
Relative Strength Index (RSI14)
Sell
Level
31.78
ADX Line
Sell
Level
50.24
Williams %R
Neutral
Level
-51.0689
50-day SMA
Sell
Level
$6.37
MACD (12, 26)
Sell
Level
-0.71
25-day Aroon Oscillator
Sell
Level
-56
On Balance Volume
Neutral
Level
25.1M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.0295)
Sell
CA Score
(Annual)
Level (-0.5545)
Sell
Beneish M-Score
(Annual)
Level (-2.1966)
Sell
Momentum Score
Level (1)
Sell
Ohlson Score
Level (1.4998)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Evolent Health, Inc. engages in the provision of healthcare delivery and payment services. It deals with population health management, health plan and third party administration, network performance and pharmacy benefit management, risk adjustment, analytics and performance improvement, and technology and electronic medical record integration. The firm operates through Services and True Health segments. The Services segment includes clinical and administrative solutions such as total cost of care management and specialty care management and comprehensive health plan administrative services. The True Health segment offers a physician-led health plan for employer-sponsored health coverage. The company was founded by Frank J. Williams, Seth B. Blackley, and Thomas Peterson III in August 2011 and is headquartered in Arlington, VA.
Stock Forecast FAQ
In the current month, EVH has received 11 Buy ratings 0 Hold ratings, and 0 Sell ratings. The EVH average analyst price target in the past 3 months is $10.18.
-
Where Will Evolent Health, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Evolent Health, Inc. share price will rise to $10.18 per share over the next 12 months.
-
What Do Analysts Say About Evolent Health, Inc.?
Analysts are divided on their view about Evolent Health, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Evolent Health, Inc. is a Sell and believe this share price will drop from its current level to $6.00.
-
What Is Evolent Health, Inc.'s Price Target?
The price target for Evolent Health, Inc. over the next 1-year time period is forecast to be $10.18 according to 11 Wall Street analysts, 11 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is EVH A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Evolent Health, Inc. is a Buy. 11 of 11 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of EVH?
You can purchase shares of Evolent Health, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Evolent Health, Inc. shares.
-
What Is The Evolent Health, Inc. Share Price Today?
Evolent Health, Inc. was last trading at $4.02 per share. This represents the most recent stock quote for Evolent Health, Inc.. Yesterday, Evolent Health, Inc. closed at $4.01 per share.
-
How To Buy Evolent Health, Inc. Stock Online?
In order to purchase Evolent Health, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get EVH Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
EVH
Sector
P/E ratio
--
23.66x
PEG ratio
-0.04x
-0.01x
P/B ratio
0.53x
1.84x
Price / LTM sales
0.22x
1.60x
Growth Metrics
EVH
Sector
Revenue growth
-22.83%
4.85%
Earnings growth
13.17%
11.15%
Revenue (5-year growth)
24.73%
6.45%
Earnings forecast
$0.10
-$0.20
Profitability
EVH
Sector
Profitability FY 2024
$247.9M
$3.6M
Return on invested capital
-6.63%
-30.98%
Return on assets
-5.08%
-27.62%
Return on equity
-13.6%
-36.69%
Earnings Date
Last Earnings Date
Nov
6
Next Earnings Date
Feb
19
Estimated Next Earnings Date
Feb
5
Balance Sheet
EVH
Sector
Total cash
$140.3M
$27.2M
Short term investments
--
$25.7M
Total assets
$2.5B
$79.9M
Long term debt
$1.1B
$4.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Google Vs NVIDIA Stock: Which Is Best?
Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…
How High Could NVIDIA Stock Go?
NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…
Stock Ideas
Sell
50
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 61x
Buy
61
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 38x
Buy
67
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 40x
Alerts
Sell
47
PSTG alert for Dec 5
Pure Storage, Inc. [PSTG] is up 5.05% over the past day.
Sell
38
HOV alert for Dec 5
Hovnanian Enterprises, Inc. [HOV] is down 22.58% over the past day.
Buy
69
ASTS alert for Dec 5
AST Spacemobile, Inc. [ASTS] is up 18.25% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
